Marker Therapeutics Inc 's ability to collect accounts receivable sequentially worsen to 2.05, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Marker Therapeutics Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 178 days, from 140 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector Marker Therapeutics inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Marker Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MRKR Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	-3.28 %	-43.98 %	-41.65 %	123.69 %	-32.76 %
Y / Y Revenue Change	-	115.32 %	-51 %	-35.99 %	-26.35 %
Receivable Turnover Ratio (TTM)	2.05	2.6	1.98	2.31	2.98
MRKR's Total Ranking	#	#	#	#	#
Accounts Receivable average collection period days	178	141	184	158	122
Seq. Receivable Change	17.58 %	0.58 %	-17.76 %	-0.55 %	-31.9 %
Seq. Revenue Change	-	-31.88 %	-10.5 %	43.17 %	146.68 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall Market	#

Receivable Turnover Ratio Statistics
High	Average	Low
0	0	0

MRKR Company Profile • Back to MRKR Efficiency Comparisons • Compare MRKR Receivables Turnover Ratio to its Competitors

Financial Statements
Marker Therapeutics Inc 's Accounts Receivable	$ 2 Millions	Visit MRKR's Balance sheet
Marker Therapeutics Inc 's Sales TTM	$ 3 Millions	Visit MRKR's Income Statement
Sources of MRKR's Revenues		Visit MRKR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
MRKR's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
MRKR's Growth Rates	MRKR's Roa	MRKR's Inventory Turnover Ratio	MRKR's Dividend Comparisons
MRKR's Profitability Ratios	MRKR's Roi	MRKR's Asset Turnover Ratio	MRKR's Dividend Growth
MRKR's Valuation Ratios	MRKR's Roe	MRKR's Financial Strength Ratios	MRKR's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Enovis Corp	5.21	$ 2,294.938 Millions	$ 440.151 Millions
The Cooper Companies Inc	5.20	$ 4,236.600 Millions	$ 814.025 Millions
Cryoport inc	5.19	$ 186.452 Millions	$ 35.933 Millions
Elutia Inc	5.16	$ 11.353 Millions	$ 2.198 Millions
Pluri Inc	5.15	$ 1.016 Millions	$ 0.197 Millions
Opus Genetics Inc	5.13	$ 9.856 Millions	$ 1.921 Millions
Carlsmed Inc	5.13	$ 62.457 Millions	$ 12.175 Millions
West Pharmaceutical Services Inc	5.12	$ 3,326.900 Millions	$ 649.250 Millions
Repligen Corp	5.09	$ 785.101 Millions	$ 154.205 Millions
Progyny Inc	5.09	$ 1,311.298 Millions	$ 257.570 Millions
Pacific Biosciences Of California Inc	5.04	$ 159.315 Millions	$ 31.630 Millions
Sarepta Therapeutics Inc	5.03	$ 1,974.344 Millions	$ 392.275 Millions
Amphastar Pharmaceuticals Inc	5.01	$ 730.019 Millions	$ 145.768 Millions
Zimmer Biomet Holdings Inc	5.00	$ 8,508.800 Millions	$ 1,700.200 Millions
Abbvie Inc	4.99	$ 64,386.000 Millions	$ 12,915.250 Millions
Pfizer Inc	4.98	$ 63,696.000 Millions	$ 12,802.250 Millions
Stereotaxis Inc	4.98	$ 29.892 Millions	$ 6.008 Millions
Invivyd Inc	4.96	$ 58.365 Millions	$ 11.776 Millions
Agilent Technologies inc	4.96	$ 7,372.000 Millions	$ 1,487.500 Millions
Cytosorbents Corporation	4.93	$ 35.663 Millions	$ 7.229 Millions
Champions Oncology Inc	4.90	$ 60.662 Millions	$ 12.388 Millions
Mirum Pharmaceuticals Inc	4.86	$ 618.067 Millions	$ 127.234 Millions
Indivior Pharmaceuticals Inc	4.85	$ 1,333.000 Millions	$ 274.750 Millions
Ultragenyx Pharmaceutical Inc	4.85	$ 717.212 Millions	$ 147.886 Millions
Abeona Therapeutics Inc	4.83	$ 30.093 Millions	$ 6.232 Millions
Xtant Medical Holdings Inc	4.81	$ 108.748 Millions	$ 22.594 Millions
Ptc Therapeutics inc	4.78	$ 1,008.754 Millions	$ 210.915 Millions
Ligand Pharmaceuticals Incorporated	4.77	$ 290.542 Millions	$ 60.966 Millions
Elanco Animal Health Incorporated	4.76	$ 5,020.000 Millions	$ 1,055.250 Millions
Personalis Inc	4.75	$ 69.669 Millions	$ 14.676 Millions

Date modified: 2026-09-12T06:13:23+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.